ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.1733T>C (p.Leu578Pro)

dbSNP: rs199474774
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002315842 SCV000674095 likely pathogenic Hereditary cancer-predisposing syndrome; Cardiovascular phenotype 2016-10-18 criteria provided, single submitter clinical testing The p.L578P variant (also known as c.1733T>C), located in coding exon 16 of the NF1 gene, results from a T to C substitution at nucleotide position 1733. The leucine at codon 578 is replaced by proline, an amino acid with similar properties. This alteration has been reported in two individuals meeting diagnostic criteria for neurofibromatosis type 1 (Jeong SY et al. J. Korean Med. Sci., 2006 Feb;21:107-12; Bausch B et al. J. Clin. Endocrinol. Metab., 2007 Jul;92:2784-92). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6501 samples (13002 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.001% (greater than 175000 alleles tested) in our clinical cohort. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV001064262 SCV001229151 pathogenic Neurofibromatosis, type 1 2023-10-20 criteria provided, single submitter clinical testing This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 578 of the NF1 protein (p.Leu578Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with neurofibromatosis type 1 (PMID: 16479075, 17426081). ClinVar contains an entry for this variant (Variation ID: 485956). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NF1 protein function. This variant disrupts the p.Leu578 amino acid residue in NF1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12746402, 23668869, 25211147). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Medical Genetics, University of Parma RCV001064262 SCV002567783 likely pathogenic Neurofibromatosis, type 1 2022-08-17 criteria provided, single submitter clinical testing
MGZ Medical Genetics Center RCV001064262 SCV002579681 likely pathogenic Neurofibromatosis, type 1 2021-11-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.